AI Chats Episode 23: Why Should Pharma Invest in Patenting AI?

Welcome to a new episode of AI Chats, a podcast series produced by the law firm of Haynes and Boone, and lawyers from its AI and Deep Learning Practice Group to explore the exciting, ever-evolving, and occasionally controversial world of artificial intelligence.

Today for our latest episode we are going to talk about Why Pharma Should Invest in Patenting AI. 

Moderator: Eugene Goryunov, Partner, Haynes and Boone

Featured Speakers: 

• Vincent Shier, Partner, Haynes and Boone
• Dina Blikshteyn, Counsel, Haynes and Boone
• Brooke Cohen, Associate, Haynes and Boone